Skip to content

Monitoring heparin anticoagulation in major vascular surgery

Monitoring heparin anticoagulation in major vascular surgery: an observational cohort study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN87607734
Enrollment
40
Registered
2015-09-25
Start date
2015-11-05
Completion date
Unknown
Last updated
2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Haematology and vascular surgery Surgery

Interventions

Enrolled patients will have additional blood tests during their surgery - withdrawal of additional 2.7 ml of blood with each monitoring episode. Up to an additional 16 ml of blood may be sampled durin

Sponsors

Royal Free London NHS Foundation Trust (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: All adult patients able to give informed consent and undergoing elective major complex vascular surgery in which heparin anticoagulation and monitoring is indicated

Exclusion criteria

Exclusion criteria: 1. <18 years old 2. Unable to consent 3. History of heparin allergy 4. Already taking part in research study

Design outcomes

Primary

MeasureTime frame
Correlate ACT and anti-Xa levels during aortic surgery - measured at baseline and up to six time points during surgery

Secondary

MeasureTime frame
1. Blood loss and bleeding will be measured during theatre 2. Clotting complications will be monitored during theatre and first week postoperatively

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026